Chemoinformaics analysis of [3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-2-octadecanoyloxypropyl] octadecanoate
Molecular Weight | 867.152 | nRot | 40 |
Heavy Atom Molecular Weight | 779.456 | nRig | 10 |
Exact Molecular Weight | 866.588 | nRing | 1 |
Solubility: LogS | -1.824 | nHRing | 0 |
Solubility: LogP | 9.166 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 146 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 59 | No. of Aromatic Carbocycles | 0 |
nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 87 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 45 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 13 | No. of Arom Bond | 0 |
nHA | 12 | APOL | 147.217 |
nHD | 6 | BPOL | 104.667 |
QED | 0.022 |
Synth | 4.642 |
Natural Product Likeliness | 0.449 |
NR-PPAR-gamma | 0.915 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.053 |
HIA | 0.514 |
CACO-2 | -5.348 |
MDCK | 0.00000238 |
BBB | 0.003 |
PPB | 0.971147 |
VDSS | 0.747 |
FU | 0.0111174 |
CYP1A2-inh | 0.004 |
CYP1A2-sub | 0.077 |
CYP2c19-inh | 0.075 |
CYP2c19-sub | 0.026 |
CYP2c9-inh | 0.069 |
CYP2c9-sub | 0.997 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.007 |
CYP3a4-inh | 0.193 |
CYP3a4-sub | 0.002 |
CL | 1.09 |
T12 | 0.071 |
hERG | 0.412 |
Ames | 0.011 |
ROA | 0 |
SkinSen | 0.953 |
Carcinogencity | 0.111 |
EI | 0.009 |
Respiratory | 0.277 |
NR-Aromatase | 0.115 |
Antiviral | Yes |
Prediction | 0.696574 |